Variant report
Variant | nsv442325 |
---|---|
Chromosome Location | chr13:110673610-110675199 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7998044 | chr13:110673614-110673615 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs139484415 | chr13:110673615-110673616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs75908495 | chr13:110673617-110673618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75832377 | chr13:110673641-110673642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9634476 | chr13:110673648-110673649 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs557102438 | chr13:110673695-110673696 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559012368 | chr13:110673741-110673742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184930418 | chr13:110673798-110673799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143166000 | chr13:110673815-110673816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78862775 | chr13:110673825-110673826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569717464 | chr13:110673834-110673835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538750993 | chr13:110673858-110673859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146696743 | chr13:110673862-110673863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572082387 | chr13:110673878-110673879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs115161551 | chr13:110673918-110673919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78970007 | chr13:110673972-110673973 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs574412013 | chr13:110673974-110673975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542933059 | chr13:110674006-110674007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189876289 | chr13:110674008-110674009 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs531783490 | chr13:110674049-110674050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181097855 | chr13:110674071-110674072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528217044 | chr13:110674074-110674075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564997703 | chr13:110674138-110674139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs527769018 | chr13:110674156-110674157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184564617 | chr13:110674161-110674162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139157310 | chr13:110674166-110674167 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530019130 | chr13:110674169-110674170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544706301 | chr13:110674189-110674190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs368191354 | chr13:110674205-110674206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs549778909 | chr13:110674240-110674241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144104339 | chr13:110674267-110674268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538417608 | chr13:110674280-110674281 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545241251 | chr13:110674289-110674290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552393108 | chr13:110674337-110674338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs565828384 | chr13:110674369-110674370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371947864 | chr13:110674489-110674490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144984986 | chr13:110674490-110674491 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs188151290 | chr13:110674517-110674518 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs78636560 | chr13:110674551-110674552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556533016 | chr13:110674556-110674557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558671368 | chr13:110674577-110674578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs576587428 | chr13:110674592-110674593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545236472 | chr13:110674606-110674607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565132398 | chr13:110674737-110674738 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77415252 | chr13:110674738-110674739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541093674 | chr13:110674763-110674764 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs544193455 | chr13:110674797-110674798 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs560763621 | chr13:110674816-110674817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182030710 | chr13:110674819-110674820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550060535 | chr13:110674827-110674828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Gastric cancer | 17908304 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Thyroid cancer | 19087340 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Mental retardation | 17124404 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21858162 | CNVD |
Melanoma | 17363583 | CNVD |
Developmental delay | 21147756 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Breast cancer | 16608533 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
abnormal development | 18461090 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Malignant glioma | 17146433 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Glioma | 17123091 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Breast cancer | 20409316 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Neurocytoma | 17123091 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Multiple myeloma | 16616336 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:110670600-110675000 | Weak transcription | Left Ventricle | heart |
2 | chr13:110670600-110675600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr13:110670600-110675600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr13:110670800-110675800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr13:110670800-110675800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr13:110670800-110676000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr13:110670800-110676000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr13:110671000-110674800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr13:110671000-110676200 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr13:110671000-110676200 | Weak transcription | Osteobl | bone |
11 | chr13:110671000-110676400 | Weak transcription | NH-A | brain |
12 | chr13:110671200-110674400 | Weak transcription | HMEC | breast |
13 | chr13:110671200-110676000 | Weak transcription | Muscle Satellite Cultured Cells | -- |
14 | chr13:110673600-110675800 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
15 | chr13:110673600-110676000 | Weak transcription | NHLF | lung |
16 | chr13:110674000-110674200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr13:110674400-110675200 | Enhancers | HMEC | breast |
18 | chr13:110674400-110675200 | Enhancers | NHEK | skin |
19 | chr13:110674800-110675000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
20 | chr13:110674800-110675000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
21 | chr13:110674800-110675800 | Enhancers | Stomach Smooth Muscle | stomach |
22 | chr13:110675000-110677000 | Enhancers | Left Ventricle | heart |
23 | chr13:110675000-110677000 | Enhancers | Right Atrium | heart |